You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
JPMorgan foresees shares of Ionis Pharmaceuticals rising another 16% from their Tuesday close after a 170% runup in six months.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.